ArticleFrontiers in cardiovascular medicine2023

Sacubitril/valsartan versus valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol.

Vivian Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.